ciprofloxacin has been researched along with epirubicin in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, JF; Chen, YY; Deng, DS; Fu, XM; Guo, ZY; Lin, YC; Shao, CL; She, ZG; Wang, CY; Yang, KL; Zheng, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cai, R; Chen, D; Chen, S; Cui, H; Li, C; Long, Y; Lu, Y; She, Z | 1 |
| Cullis, PR; Fenske, DB; Maurer, N; Maurer-Spurej, E; Wong, KF | 1 |
| de Vries, EG; Hospers, GA; Mulder, NH; Schröder, CP; Sleijfer, DT; van der Graaf, WT; Willemse, PH | 1 |
| Burgués, JP; Gómez, L; Jiménez-Cruz, JF; Ozonas, M; Pontones, JL; Vera, CD | 1 |
| Anami, S; Fujii, C; Kitada, N; Kondoh, M; Minegaki, T; Morita, S; Nishino, M; Takara, K; Watari, M; Yasuda, J | 1 |
| Drewa, T; Gurtowska, N; Kloskowski, T | 1 |
| Engeler, DS; Ludewig, B; Scandella, E; Schmid, HP | 1 |
2 review(s) available for ciprofloxacin and epirubicin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Ciprofloxacin criteria in antimicrobial prophylaxis and bladder cancer recurrence.
Topics: Anti-Infective Agents; Antineoplastic Agents; Carcinoma, Transitional Cell; Cell Line, Tumor; Ciprofloxacin; Dose-Response Relationship, Drug; Doxorubicin; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Epirubicin; Humans; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms | 2010 |
2 trial(s) available for ciprofloxacin and epirubicin
| Article | Year |
|---|---|
Prevention of febrile leucopenia after chemotherapy in high-risk breast cancer patients: no significant difference between granulocyte-colony stimulating growth factor or ciprofloxacin plus amphotericin B.
Topics: Adult; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Ciprofloxacin; Costs and Cost Analysis; Cyclophosphamide; Drug Therapy, Combination; Epirubicin; Female; Fever; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Length of Stay; Leukopenia; Methotrexate; Middle Aged; Neoplasm Metastasis; Netherlands; Prospective Studies; Recombinant Proteins | 1999 |
[Equalization of breast cancer chemotherapy at general hospital( II )-evaluation of safety in FEC and TC regimens].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Breast Neoplasms; Ciprofloxacin; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Hospitals, General; Humans; Japan; Middle Aged; Neutropenia; Taxoids | 2009 |
8 other study(ies) available for ciprofloxacin and epirubicin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Bioactive hydroanthraquinones and anthraquinone dimers from a soft coral-derived Alternaria sp. fungus.
Topics: Alternaria; Animals; Anthozoa; Anthraquinones; Anti-Bacterial Agents; Antineoplastic Agents; Drug Screening Assays, Antitumor; HCT116 Cells; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular | 2012 |
Cytotoxic and Antibacterial Preussomerins from the Mangrove Endophytic Fungus Lasiodiplodia theobromae ZJ-HQ1.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Ascomycota; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Endophytes; HeLa Cells; Hep G2 Cells; Humans; MCF-7 Cells; Mitosporic Fungi; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Staphylococcus aureus | 2016 |
Factors influencing uptake and retention of amino-containing drugs in large unilamellar vesicles exhibiting transmembrane pH gradients.
Topics: Amines; Ammonium Sulfate; Ciprofloxacin; Doxorubicin; Drug Carriers; Epirubicin; Hydrogen-Ion Concentration; Liposomes; Pharmaceutical Preparations; Phosphatidylcholines; Phosphatidylglycerols; Solubility; Vincristine | 1999 |
A chemosensitivity test for superficial bladder cancer based on three-dimensional culture of tumour spheroids.
Topics: Antineoplastic Agents; Ciprofloxacin; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Epirubicin; Humans; Mitomycin; Spheroids, Cellular; Thiotepa; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Verapamil | 2007 |
Ciprofloxacin and epirubicin synergistically induce apoptosis in human urothelial cancer cell lines.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Synergism; Epirubicin; Female; Flow Cytometry; Humans; Male; Middle Aged; Time Factors; Urologic Neoplasms; Urothelium | 2012 |